Duncan Williams Asset Management LLC Raises Holdings in Danaher Corporation $DHR

Duncan Williams Asset Management LLC boosted its position in Danaher Corporation (NYSE:DHR) by 4.1% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,510 shares of the conglomerate’s stock after purchasing an additional 100 shares during the quarter. Duncan Williams Asset Management LLC’s holdings in Danaher were worth $496,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in DHR. Sendero Wealth Management LLC acquired a new stake in shares of Danaher in the second quarter valued at about $799,000. Valeo Financial Advisors LLC raised its holdings in Danaher by 8.2% in the 2nd quarter. Valeo Financial Advisors LLC now owns 12,638 shares of the conglomerate’s stock valued at $2,496,000 after acquiring an additional 963 shares during the last quarter. Plimoth Trust Co. LLC lifted its stake in Danaher by 50.1% in the 2nd quarter. Plimoth Trust Co. LLC now owns 2,605 shares of the conglomerate’s stock worth $515,000 after purchasing an additional 870 shares in the last quarter. David Wealth Management LLC lifted its stake in Danaher by 0.5% in the 2nd quarter. David Wealth Management LLC now owns 30,340 shares of the conglomerate’s stock worth $5,993,000 after purchasing an additional 147 shares in the last quarter. Finally, Marks Group Wealth Management Inc boosted its holdings in shares of Danaher by 4.5% during the 2nd quarter. Marks Group Wealth Management Inc now owns 5,568 shares of the conglomerate’s stock worth $1,100,000 after purchasing an additional 239 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analysts Set New Price Targets

DHR has been the topic of a number of analyst reports. Scotiabank upgraded Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price objective on the stock in a research report on Friday, July 11th. Guggenheim reiterated a “buy” rating and set a $250.00 price target on shares of Danaher in a report on Wednesday, July 23rd. Bank of America lowered their price target on shares of Danaher from $230.00 to $220.00 and set a “buy” rating on the stock in a research report on Monday, September 22nd. Evercore ISI cut their price objective on shares of Danaher from $230.00 to $226.00 and set an “outperform” rating for the company in a research report on Tuesday, July 8th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Danaher in a report on Saturday, September 27th. Seventeen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $245.91.

Insider Activity

In related news, Director Teri List sold 2,778 shares of the stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director owned 20,751 shares of the company’s stock, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 11.10% of the company’s stock.

Danaher Price Performance

Shares of DHR opened at $211.65 on Tuesday. The firm has a 50-day simple moving average of $200.36 and a two-hundred day simple moving average of $197.24. The stock has a market cap of $151.55 billion, a PE ratio of 45.03, a P/E/G ratio of 3.06 and a beta of 0.77. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $279.41. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping analysts’ consensus estimates of $1.64 by $0.16. The firm had revenue of $5.94 billion during the quarter, compared to analysts’ expectations of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm’s quarterly revenue was up 3.4% on a year-over-year basis. During the same quarter last year, the company posted $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, analysts forecast that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a $0.32 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. Danaher’s payout ratio is presently 27.23%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.